NL-OMON41699
已完成
不适用
Factors influencing the outcome of nilotinib treatment in patients with chronic myeloid leukemia in daily practice - Response and Adherence to Nilotinib in Daily practice (RAND-study)
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Chronic Myelogenous Leukemia
- 发起方
- Vrije Universiteit Medisch Centrum
- 入组人数
- 70
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •\- Male or female patients \>\= 18 years of age
- •\- ECOG 0, 1, or 2\.
- •\- Diagnosis of chronic myelogenous leukemia with cytogenetic confirmation of Philadelphia chromosome of (9;22\) translocations.
- •\- Treatment with nilotinib.
排除标准
- •\- Inability to grant consent.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
1 期
Treatment for patients whith graft-versus-host disease after bone marrow transplantation.Chronic graft-versus-host disease .MedDRA version: 14.1Level: LLTClassification code 10008907Term: Chronic GVH diseaseSystem Organ Class: 100000004870Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000770-36-BECHU-ULg5
尚未招募
不适用
Efficacy and safety evaluation of nilotinib as primary treatment in newly diagnosed Philadelphia chromosome positive(Ph+) chronic myeloid leukemia(CML) patientsDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000615Seoul National University Hospital114
招募中
2 期
Clinical study evaluating efficacy of Nilotinib in CML patientsChronic myelogenous leukemiaJPRN-UMIN000002579ara Hospital Kinki University School Of Medicine20
进行中（未招募）
1 期
A Phase II Trial of Nilotinib in the Treatment of Patients with c-KIT Mutated Advanced Acral and Mucosal Melanoma (NICAM) - Nilotinib in the Treatment of c-KIT Mutated Melanoma (NICAM)c-KIT mutated advanced acral or mucosal melanomaMedDRA version: 10 Level: LLT Classification code 10025654 Term: Malignant melanoma of sites other than skinMedDRA version: 10 Level: LLT Classification code 10000583 Term: Acral lentiginous melanomaEUCTR2009-012945-49-GBRoyal Marsden Hosptial Foundation Trust29
已完成
不适用
Prognostic and predictive factors of lenvatinib in patients with hepatocellular carcinomaJPRN-UMIN000036625Kitasato University Hospital100